MedTrace Logo

DRy Eye Outcome and Prescription Study

NCT03652415 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 635

Last updated 2018-08-31

No results posted yet for this study

Summary

The DRy eye Outcome and Prescription Study (DROPS) is a large observational multicentre study exploring the 'real world' effectiveness of artificial tears in dry eye disease and determinants of efficacy. The aim is to include at least 635 symptomatic dry eye patients who are prescribed artificial tears. All trainees and fellows in London are invited to become collaborators: collaborators are asked to consent patients, assess signs at baseline, and give patients questionnaires at baseline and 4 weeks (for home completion). In tandem, we are conducting a qualitative review of ophthalmologists' prescribing behaviours for dry eye disease.

Conditions

  • Dry Eye
  • Dry Eye Syndrome
  • Blepharitis
  • Meibomian Gland Dysfunction
  • Eye Pain
  • Punctate Epithelial Keratitis
  • Punctate Keratitis
  • Tear Film Insufficiency
  • Kerato Conjunctivitis Sicca
  • Eye Diseases

Interventions

DEVICE

Artificial tears (classified by MHRA as a medical device)

Use of artificial tears

Sponsors & Collaborators

  • Fight for Sight

    collaborator OTHER

  • Guy's and St Thomas' NHS Foundation Trust

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-23
Primary Completion
2021-08-23
Completion
2021-08-23

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03652415 on ClinicalTrials.gov